Kushev Daniel, Gorneva Galina, Enchev Venelin, Naydenova Emilya, Popova Julita, Taxirov Svetoslav, Maneva Liliana, Grancharov Konstantin, Spassovska Nadejda
Institute of Molecular Biology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str. bl. 21, BG-1113 Sofia, Bulgaria.
J Inorg Biochem. 2002 Apr 28;89(3-4):203-11. doi: 10.1016/s0162-0134(01)00420-2.
New platinum(II) complexes of 3-aminocyclohexanespiro-5-hydantoin (achsh) were prepared and characterized. Ab initio calculation of the structure and the measurements of IR and NMR spectra of [Pt(NH(3))(achsh)Cl(2)] were also performed. Quantum-chemical and spectroscopic studies indicated a cis-square planar structure with a hydantoin ligand coordinated via the NH(2) group. The complexes were evaluated for in vitro cytotoxicity in murine erythroleukemia (MEL) cells, clone F4N, as well as for in vivo antitumor activity toward murine L1210 leukemia. The complexes exerted significantly lower in vitro and in vivo toxicities compared with those of cisplatin (cis-diamminedichloroplatinum(II), DDP). The complex [Pt(NH(3))(achsh)Cl(2)] exhibited antitumor activity against L1210 leukemia, comparable to that of cisplatin, resulting at a dose of 72 mg/kg in a %T/C (increased survival time) of 191%. This complex, as well as cisplatin, induced apoptosis in F4N cells, and exerted antibacterial activity as assessed in 10 bacterial strains.
